The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Roche and biotech company Prothena are set to advance their Parkinson’s disease candidate prasinezumab into a phase 2b efficacy trial following some promising results in an earlier trial. ... In 2013, Roche and Prothena entered a collaboration
Swiss pharma giant Roche has partnered with Cambridge, Massachusetts-based Dyno Therapeutics for the development of gene therapies for central nervous system (CNS) and liver diseases. ... The Roche deal is Dyno’s third pharma collaboration, in addition
LiverSync. by Norgine. with support from earthware. #PutCancerToTheTest. by Roche. with support from Galliard Healthcare Communications. ... The What If? Accelerator. by Roche. with support from Virgo Health.
In August, Regeneron also signed a deal with Roche to bolster manufacturing and global development capabilities for the antibody cocktail. ... The collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times its
This means it beats a number of competitors to the punch – including Merck &Co’s Keytruda (pembrolizumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab), which are all studying their ... This includes Roche’s Tecentriq,
[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...